These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32430839)

  • 1. Number of prior negative screening outcomes does not influence future risk of breast cancer.
    Lilleborge M; Falk RS; Hofvind S
    Eur J Epidemiol; 2020 Jun; 35(6):549-556. PubMed ID: 32430839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
    Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
    Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
    Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
    Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
    Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
    Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mammography screening history a predictor of future breast cancer risk?
    Andersen SB; Törnberg S; Kilpeläinen S; Von Euler-Chelpin M; Njor SH
    Eur J Epidemiol; 2015 Feb; 30(2):143-9. PubMed ID: 25421784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
    Sebuødegård S; Botteri E; Hofvind S
    J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme.
    Bhargava S; Tsuruda K; Moen K; Bukholm I; Hofvind S
    J Med Screen; 2018 Sep; 25(3):155-161. PubMed ID: 29059006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
    Tsuruda KM; Larsen M; Román M; Hofvind S
    Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
    Morrell S; Taylor R; Roder D; Dobson A
    J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study.
    Puliti D; Zappa M; Giorgi Rossi P; Pierpaoli E; Manneschi G; Ambrogetti D; Ventura L; Mantellini P;
    Breast Cancer Res; 2018 Aug; 20(1):95. PubMed ID: 30092817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.
    Roman M; Skaane P; Hofvind S
    Eur J Radiol; 2014 Sep; 83(9):1639-44. PubMed ID: 24972452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen Victoria.
    Houssami N; Lockie D; Clemson M; Pridmore V; Taylor D; Marr G; Evans J; Macaskill P
    Med J Aust; 2019 Oct; 211(8):357-362. PubMed ID: 31448816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
    Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
    Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in breast cancer risk distribution among Vermont women using screening mammography.
    Bolton KC; Mace JL; Vacek PM; Herschorn SD; James TA; Tice JA; Kerlikowske K; Geller BM; Weaver DL; Sprague BL
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24957223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.